Investor Relations-ZHEJIANG BENLI TECHNOLOGY CO., LTD.- A pharmaceutical company

Home page

Investor Relations/ INVESTOR RELATIONS

Staff style

Company news

Industry news

Periodic announcements

Temporary Announcement

04-27

2023

Verification opinion of Great Wall Securities Co., Ltd. on the 2022 internal control self-evaluation report of Zhejiang Benli Technology Co., Ltd.

05-04

2023

Announcement on Reply to Letter of Concern of Shenzhen Stock Exchange

05-12

2023

Announcement on Holding 2022 Online Performance Briefing

< 1...8 9 10...14 >

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Hotline: 0576-85580770

E-mail: blkj@benlitech.com

Address: Linhai Toumen Port, Taizhou City, Zhejiang Province
No.15, Donghai Sixth Avenue, New District

Company official website

Public Number

Business License